Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
Jotup,
SINGAPORE, June 29, 2023 /PRNewswire/ -- Biosyngen, an immune-oncology company with technology targeting the unmet medical…
SINGAPORE, June 29, 2023 /PRNewswire/ -- Biosyngen, an immune-oncology company with technology targeting the unmet medical…
New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatment SINGAPORE, June 29…
News provided by Biosyngen Jun 29, 2023, 4:58 AM ET New state-of-the-art facility to develop immunotherapy assets to address…
New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatment SINGAPORE, June 29…